Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.41 USD | -1.45% | -8.02% | +132.43% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+132.43% | 155M | |
+64.54% | 62.59B | |
-0.93% | 41.18B | |
+44.76% | 40.29B | |
-8.29% | 27.9B | |
+13.29% | 26.21B | |
-21.51% | 19.09B | |
+5.16% | 13.08B | |
+25.21% | 12.26B | |
+28.25% | 12.05B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- HC Wainwright Adjusts Cardiff Oncology's Price Target to $25 from $26, Keeps Buy Rating